Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Dopamine reuptake inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H29NO2 |
InChIKeyAPOIWLPBSSEELA-UHFFFAOYSA-N |
CAS Registry2377477-63-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Preclinical | CN | 14 Feb 2019 |